References

[1]  UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2010.

[2]  Centers for Disease Control (CDC). Unintended pregnancy prevention. Atlanta: CDC; 2011. Available online at: http://www.cdc.gov/reproductive health/Unintended Pregnancy/index.htm [verified July 2011].

[3]  Cohen MS, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 2011; 365: 493–505.
| CrossRef | CAS |

[4]  Abdool Karim Q, Abdool-Karim S, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168–74.
| CrossRef | CAS |

[5]  Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363: 2587–99.
| CrossRef | CAS |

[6]  Baeten J, Donnell D, Celum C. Pre-exposure prophylaxis with antiretroviral drugs in men and women in Africa. 6th IAS Pathogenesis Meeting; July 18, 2011; Rome, Italy.

[7]  Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger I, et al Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643–56.
| CrossRef |

[8]  Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 2007; 369: 657–66.
| CrossRef |

[9]  Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, et al Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff 2009; 28: 1591–605.
| CrossRef |

[10]  Crosby R, Warner L. Pending issues in male condom use promotion. Sex Health 2008; 5: 317–9.
| CrossRef |

[11]  Warner L, Gallo M, Macaluso M. Condom use around the globe: how can we fulfill the prevention potential of male condoms? Sex Health 2012; 9: 4–9.
| CrossRef |

[12]  Crosby RA, Bounce S. Condom effectiveness: where are we now? Sex Health 2012; 9: 10–17.
| CrossRef |

[13]  Gallo M, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health 2012; 9: 18–26.
| CrossRef |

[14]  Zou H, Xue H, Wang X, Lu D. Condom use in China: prevalence, policies, issues and barriers. Sex Health 2012; 9: 27–33.
| CrossRef |

[15]  Amirkhanian YA. Review of HIV vulnerability and condom use in central and eastern Europe. Sex Health 2012; 9: 34–43.
| CrossRef |

[16]  Chapman S, Jafa K, Longfield K, Vielot N, Buszin J, Ngamkitpaiboon C, Kays M. Condom social marketing in sub-Saharan Africa and the Total Market Approach. Sex Health 2012; 9: 44–50.
| CrossRef |

[17]  Beksinska M, Smit JA, Mantell JE. Progress and challenges to male and female condom use in South Africa. Sex Health 2012; 9: 51–58.
| CrossRef |

[18]  Maticka-Tyndale E. Condoms in sub-Saharan Africa. Sex Health 2012; 9: 59–72.
| CrossRef |

[19]  Higgins J, Cooper AD. Dual use of condoms and contraceptives in the USA. Sex Health 2012; 9: 73–80.
| CrossRef |

[20]  Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012; 9: 81–95.
| CrossRef |

[21]  Crosby RA, Ricks J, Young A. Condom migration resulting from circumcision, microbicides, and vaccines: brief review and methodological considerations. Sex Health 2012; 9: 96–102.
| CrossRef |

[22]  Graham CA. Condom use in the context of sex research. Sex Health 2012; 9: 103–108.
| CrossRef |

[23]  Cates W, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis 2002; 29: 168–74.
| CrossRef |